News

Krystal Biotech Announces European Commission Approval Of VYJUVEK® For The Treatment Of Dystrophic Epidermolysis Bullosa
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as p ...
Le Lézard18h
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
InMode Ltd. ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended. First Quarter 2025 Highlights: ...
InMode Ltd.: InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
Completed Recent Share Repurchase Program of 6.95 Million Shares YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") ...
The Huntington News6h
Five years later, Northeastern students reflect on COVID-19 lockdowns
President Donald Trump declared COVID-19 a national emergency. What followed was nearly a year of lockdowns, then a year of ...